Can Pharmacogenetic Variants in TPMT, MTHFR and SLCO1B1 Genes Be Used as Potential Markers of Outcome Prediction in Systemic Sclerosis Patients?

por Jelovac, Marina, Kotur, Nikola, Ristivojevic, Bojan, Pavlovic, Djordje, Spasovski, Vesna, Damjanov, Nemanja, Pavlovic, Sonja, Zukic, Branka
Publicado 2023

Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations

por Stanković, Biljana, Kotur, Nikola, Gašić, Vladimir, Klaassen, Kristel, Ristivojević, Bojan, Stojiljković, Maja, Pavlović, Sonja, Zukić, Branka
Publicado 2020

Pharmacogenomic Markers of Methotrexate Response in the Consolidation Phase of Pediatric Acute Lymphoblastic Leukemia Treatment

por Kotur, Nikola, Lazic, Jelena, Ristivojevic, Bojan, Stankovic, Biljana, Gasic, Vladimir, Dokmanovic, Lidija, Krstovski, Nada, Milosevic, Goran, Janic, Dragana, Zukic, Branka, Pavlovic, Sonja
Publicado 2020

Genome-Wide Association Study of COVID-19 Outcomes Reveals Novel Host Genetic Risk Loci in the Serbian Population

por Zecevic, Marko, Kotur, Nikola, Ristivojevic, Bojan, Gasic, Vladimir, Skodric-Trifunovic, Vesna, Stjepanovic, Mihailo, Stevanovic, Goran, Lavadinovic, Lidija, Zukic, Branka, Pavlovic, Sonja, Stankovic, Biljana
Publicado 2022